Newsroom
September 28, 2022
Findings reported in Nature have implications for future dementia care, as well. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 28, 2022) — Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are part of an international team that discovered 61 additional genetic loci associated with stroke and […]
September 22, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 22, 2022) — Debra Gutierrez of Von Ormy, Texas, near San Antonio has been an active person all her life. An ophthalmology technician at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), she works in a clinic that sees scores […]
June 15, 2022
Drug conceived at UT Health San Antonio was safe, effective in animal studies Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) — An experimental brain injury medication conceived in laboratories at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was tested Tuesday, […]
April 20, 2022
Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.
April 19, 2022
Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway. […]
April 14, 2022
Researchers from UT Health San Antonio today reported the discovery of a novel mechanism by which pathological forms of tau protein cause neurons to die. Alzheimer’s disease and chronic traumatic encephalopathy (CTE) are among more than 20 disorders that include tau protein pathology. The newly found mechanism of tau-induced damage can be altered pharmacologically, the scientists noted, making it a novel target for drug development.
